Media &amp; Publications

Press Releases

Submitted posters of our APML 2023 Annual Meeting.

April 16, 2024

2024 APMLPR Annual Meeting Registration Form

Registration Form

January 18, 2024

An Introduction to 3D Pathology

Dr. Nick Reder's presentation from our 2023 Fall Meeting.

3D Prostate Pathology

Dr. Nick Reder's presentation from our 2023 Fall Meeting.

Foundational Components and Value of Large-Scale Digital Pathology Deployment

Dr. Dibson Dibe Gondim's presentation from our 2023 Fall Meeting.

AI in the Pathologist's Toolbox

Dr. Dibson Dibe Gondim's presentation from our 2023 Fall Meeting.

APML 2023 Fall Meeting Registration Form

Registration Form

August 12, 2023

Biopsy and surgical specimen specific deep learning models for prostate cancer detection on digitized pathology images

Differences in morphology and heterogeneity drive performance differences between cancer detection models trained on different sample types. Our results suggest that these morphological differences can be overcome with sample type specific models or training set optimization methods.

Member Publications

June 29, 2023

Young male with scrotal swelling

A 28-year-old male who recently visited the urologist refers dull pain in the left groin.

May 26, 2023

Malakoplakia of the Urogenital Tract

We discuss the need for a high index of suspicion and careful scrutiny of histology to order to avoid misdiagnosis as simple long term antibiotics are an effective treatment in all but those with large pelvic masses.

May 15, 2023

Bladder malakoplakia: A case report

Bladder malacoplakia is a rare chronic granulomatous lesion. The disease was first reported by Michaelis and Gutmann in 1902, and its most common site was the urinary system, followed by the reproductive tract, gastrointestinal tract, and retroperitoneum. The etiology of this disease is complex, and its clinical misdiagnosis rate is high.

May 15, 2023

52 y/o man with chronic urinary tract infections

52-year-old man was referred to the urologist due to a marked decrease in the voiding stream caliber, postvoid dribbling, hematuria, and urinary retention.

May 15, 2023

Small Cell Carcinoma of the Prostate

SCC of the prostate has a presentation that is distinct from its adenocarcinoma counterparts; unique features include an unresponsiveness to hormonal therapy, rapid progression, increased risk of lytic bone lesions, presence of visceral metastases, a markedly enlarged prostate, and low PSA relative to disease burden.

May 9, 2023

Small Cell Carcinoma of the Prostate: A Case Report and Review of the Literature

In this report, we discuss the case of a 63-year-old African American male who initially presented to the hospital with an elevated prostate-specific antigen (PSA) level of 9.41 ng/mL and was found to have locally extensive SCCP.

May 9, 2023

Large Prostatic Mass in a Geriatric Patient

64-year-old male patient was referred to the urologist due to 7.41 ng/mL PSA levels.

May 9, 2023

FNA Workshop - Models to Optimize Accuracy in Interventional Cytopathology

Dr. Luis E. De Las Casas's presentation from our 2023 Annual Meeting.

Potpourri of Salivary Gland Lesions Cyto-Histopathogical Correlations

Dr. Glorimar Rivera Colón's presentation from our 2023 Annual Meeting.

Cyto-Histopathological Correlations in Gynecologic Pathology Selective Challenges

Dr. Glorimar Rivera Colón's presentation from our 2023 Annual Meeting.

Mysteries of Molar Pregnancies

Dr. Diego H. Castrillón's presentation from our 2023 Annual Meeting.

Endometrial Hyperplasia Problems, Updates and Future Directions

Dr. Diego H. Castrillón's presentation from our 2023 Annual Meeting.

Ovarian Sex Cord-Stromal Tumors - Selective Diagnostic Challenges and Recent Updates

Dr. Wenxin Zheng's presentation from our 2023 Annual Meeting.

Molecular Classification of Endometrial Cancer - What is the Current Situation?

Dr. Wenxin Zheng's presentation from our 2023 Annual Meeting.

Hodgkin Lymphoma for the Surgical Pathologist

Dr. Aaron Auerbach's presentation from our 2023 Annual Meeting.

Small B-cell Lymphoma with Updates from the WHO Blue Book

Dr. Aaron Auerbach's presentation from our 2023 Annual Meeting.

Enterobius vermicularis causing acute appendicitis, a case report with literature review.

Enterobius vermicularis can habit the appendix and induce the signs and symptoms of A.A with or without actual histopathological acute appendicitis. The treatment of choice is surgical resection of the appendix.

Acute suppurative appendicitis associated with Enterobius vermicularis: an incidental finding or a causative agent? A case report.

Acute appendicitis due to E. vermicularis is a very rare occurrence. The histopathological analysis of resected specimens should pay special attention to search for this parasite for adequate post-operative treatment of patients.

Pediatric Acute Abdominal Pain

10 y/o boy presents with acute abdominal pain in the RLQ.

Posters - APML Spring 2023

Submitted posters of our APML 2023 Annual Meeting.

March 30, 2023

What is new with the 2021 WHO Classification of Tumors of the Central Nervous System: An update in glioma diagnosis

Dr. Marie L. Rivera-Zengotita's presentation from our 2022 Annual Meeting.

What is new with the 2021 WHO Classification of Tumors of the Central Nervous System: An overview of non-glial tumors

Dr. Marie L. Rivera-Zengotita's presentation from our 2022 Annual Meeting.

Indeterminate thyroid nodules- Cytology-Histology Correlations and Updates in the Bethesda system

Dr. Rema A. Rao's presentation from our 2022 Annual Meeting.

Indeterminate thyroid nodules- A pragmatic morpho- molecular approach in the era of molecular testing

Dr. Rema A. Rao's presentation from our 2022 Annual Meeting.

Classification of Cutaneous Vascular Neoplasms

Dr. Michael Royer's presentation from our 2022 Annual Meeting.

Artificial Intelligence in Breast Pathology

Dr. Liron Pantanowitz's presentation from our 2022 Annual Meeting.

Artificial Intelligence & Anatomical Pathology: Feasibility for Clinical Practice

Dr. Liron Pantanowitz's presentation from our 2022 Annual Meeting.

A Practical Approach to Inflammatory Dermatopathology

Dr. Michael Royer's presentation from our 2022 Annual Meeting.

Intracranial myxoid mesenchymal neoplasms with EWSR1 gene rearrangement: report of 2 midline cases with one demonstrating durable response to MET inhibitor monotherapy

EWSR1 fusions have been identified in multiple neoplasms involving bone and soft tissue. Recently, cases of intracranial myxoid mesenchymal neoplasms harboring EWSR1-CREB family gene fusions have been reported in young patients with histologic features reminiscent of the myxoid variant of angiomatoid fibrous histiocytoma.

Validating Whole Slide Imaging Systems for Diagnostic Purposes in Pathology

The College of American Pathologists convened an expert panel to update the guideline following standards established by the National Academies of Medicine for developing trustworthy clinical practice guidelines.

Cytomorphologic Features of Intraductal Salivary Gland Carcinoma: A Multi-Institutional Study of 13 FNA Cases With Histologic, Molecular, and Clinical Correlations

Intraductal carcinoma of the salivary gland (IDC) is an uncommon salivary gland malignancy. It was first described in 1983 by Chen, and it has previously been called low-grade (LG) salivary duct carcinoma and LG cribriform cystadenocarcinoma.

Squamous Cell Carcinoma With Perineural Involvement in Nevus Sebaceus

A 13-year-old fair-skinned adolescent girl presented with a hairless 2×2.5-cm yellow plaque at the hairline on the anterior central scalp.

Posters - APML Spring 2022

Submitted posters of our APML Spring 2022 Meeting.

Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry

Fusions involving NTRK1, NTRK2, and NTRK3 are oncogenic drivers occurring in a spectrum of mesenchymal neoplasms ranging from benign to highly malignant tumors.

Detection of Tumor NTRK Gene Fusions to Identify Who May Benefit from TRK Inhibitor Therapy

NTRK gene fusions have been shown to be actionable genomic events that are predictive of response to TRK kinase inhibitors.

NTRK Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects

NTRK 1, 2, and 3 activation plays an important role in cell cycle proliferation and survival.